alexa Epidemiologic Study And Mutation Profile Of Patients With Chronic Myeloid Leukemia (CML) In Indonesia
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Hematology & Blood Disorders
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Arry Harryanto Reksodiputro
Accepted Abstracts: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.008
Abstract
The aim of this study is to perform an epidemiologic study of CML and to see the influence of BCR ABL mutation on the response to Imatinib (IM) of CML patients in Indonesia. This study was a cross sectional, open-label, single arm, non randomized study. The samples were CML patients from 6 centers in Indonesia who were treated with IM during January 1st, 2009 up to December 31st, 2011. The inclusion criterion was male or female 17-70 years old and was confirmed as CML by the BCR ABL PCR method. The BCR ABL gene mutation is studied by the Sanger direct sequencing method. Of the 100 CML patients studied, the median age was 34-35 years old. 67% CML patients in this study had been treated with hydroxyurea before IM was started. The patient who consumed hydroxyurea more than 6 months had more difficult to give complete hematologic response in 3 months than those who consumed hydroxyurea in less than 6 month. Interestingly, there were two blastic crisis CML patients who achieved chronic phase again and complete hematologic response within 3-5 month subsequently. 89% patients were still alive until 2 years follow up. Of 51 patients who had the sequencing test performed, 15 had mutations of their BCR ABL gene. One patient had P-loop mutation, while 14 patients had non P-loop mutations. The patient with P-loop mutation did not achieve complete hematologic response in 3 month. Six of 15 patients with mutation were non responsive to imatinib, while 9 of 15 patients with mutation could achieved complete hematologic response in 3 months.
Biography
Arry Harryanto Reksodiputro completed his PhD from Leiden University. He is now a Professor in Faculty of Medicine, University of Indonesia, and also President of ISHMO (The Indonesian Society of Hematology-Medical Oncology).
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version